P66Shc (Shc1) Zebrafish Mutant Line as a Platform for Testing Decreased Reactive Oxygen Species in Pathology

Area of Science:

• Cardiovascular Research
• Zebrafish Models
• Reactive Oxygen Species Biology

Background:

• Reactive oxygen species (ROS) dysregulation is implicated in numerous pathologies.
• Existing in vivo models for studying ROS-related diseases often neutralize ROS non-specifically, impacting both beneficial and detrimental ROS levels.
• Targeting specific ROS-producing enzymes, like p66Shc, is a newer strategy for studying ROS-mediated pathologies.

Purpose of the Study:

• To evaluate a zebrafish heterozygote p66Shc hypomorphic mutant line as a model for low-ROS myocardial infarction (MI).
• To assess if this zebrafish line can mimic mammalian MI while maintaining a low-ROS background.
• To investigate the potential of this model for studying ROS-mediated cardiovascular pathology.

Main Methods:

• Development and characterization of a zebrafish heterozygote p66Shc hypomorphic mutant line.
• Evaluation of the mutant line for associated phenotypes, including body mass and tissue ROS levels.
• Assessment of the mutant line's utility as a model for myocardial infarction (MI) pathology.

Main Results:

• The p66Shc hypomorphic zebrafish line exhibits no significant negative phenotype.
• This zebrafish line demonstrates decreased body mass and lower tissue ROS levels.
• The reduced ROS levels in this model confer protection against ROS-mediated pathology.

Conclusions:

• The p66Shc hypomorphic zebrafish line serves as a viable low-ROS model for studying myocardial infarction (MI).
• This model offers a unique platform to investigate ROS-mediated diseases without the confounding effects of broad ROS neutralization.
• The findings suggest this zebrafish line can provide novel insights into cardiovascular pathology and related diseases.